{
  "id": "78063f24c122bf44",
  "title": "Nurix Therapeutics Outlines 2026 Goals and Objectives for Advancing Bexobrutideg and Its Pipeline of Novel Degrader - Based Medicines in Cancer and Autoimmune Diseases",
  "description": "20260112T124500Z",
  "content": "",
  "source": "manilatimes.net",
  "source_url": "https://www.manilatimes.net/2026/01/12/tmt-newswire/globenewswire/nurix-therapeutics-outlines-2026-goals-and-objectives-for-advancing-bexobrutideg-and-its-pipeline-of-novel-degrader-based-medicines-in-cancer-and-autoimmune-diseases/2256987",
  "published_at": "20260112T124500Z",
  "fetched_at": "2026-01-13T00:20:01.657666+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "Philippines",
  "raw_data": {
    "url": "https://www.manilatimes.net/2026/01/12/tmt-newswire/globenewswire/nurix-therapeutics-outlines-2026-goals-and-objectives-for-advancing-bexobrutideg-and-its-pipeline-of-novel-degrader-based-medicines-in-cancer-and-autoimmune-diseases/2256987",
    "url_mobile": "https://www.manilatimes.net/2026/01/12/tmt-newswire/globenewswire/nurix-therapeutics-outlines-2026-goals-and-objectives-for-advancing-bexobrutideg-and-its-pipeline-of-novel-degrader-based-medicines-in-cancer-and-autoimmune-diseases/2256987/amp",
    "title": "Nurix Therapeutics Outlines 2026 Goals and Objectives for Advancing Bexobrutideg and Its Pipeline of Novel Degrader - Based Medicines in Cancer and Autoimmune Diseases",
    "seendate": "20260112T124500Z",
    "socialimage": "https://www.manilatimes.net/manilatimes/uploads/images/2026/01/12/896173.jpg",
    "domain": "manilatimes.net",
    "language": "English",
    "sourcecountry": "Philippines"
  }
}